Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection (SHERLOC)
This study has suspended participant recruitment.
( Study drug currently unavailable )
Study NCT00811863   Information provided by Mallinckrodt

First Received on December 18, 2008.   Last Updated on March 15, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nephrogenic Systemic Fibrosis
Renal Insufficiency
Additional conditions recognized in this trial
Fibrosis
Nephrogenic Fibrosing Dermopathy
Renal Insufficiency, Chronic
More general conditions related to this trial
Kidney Diseases
Pathologic Processes
Skin Diseases
Urologic Diseases
Sponsors listed in this trial
Mallinckrodt


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services